Status:
ACTIVE_NOT_RECRUITING
A Study Of Virtual Reality Vs Sham VR On Fibromyalgia
Lead Sponsor:
Mayo Clinic
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to understand the therapeutic impact of VR on Fibromyalgia symptoms and potentially increase the scope of treatment options for patients suffering from Fibromyalgia.
Eligibility Criteria
Inclusion
- Adults aged \>18 years old
- Diagnosis of fibromyalgia based on ACR 2016 criteria
- Stable on current medications and non-pharmacologic treatments for 4 weeks
- Ability and willingness to use a Meta Quest 3 VR headset Fluent in English
- Provide informed consent
Exclusion
- History of seizures or conditions contraindicating VR use
- Severe psychiatric illness (e.g., psychosis)
- Cognitive impairment interfering with study participation
- Participation in other interventional trials
Key Trial Info
Start Date :
September 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07202572
Start Date
September 29 2025
End Date
December 31 2025
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224